Navigation Links
Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
Date:4/1/2011

BALTIMORE, Md., April 1, 2011 /PRNewswire/ -- Champions Biotechnology, Inc. (OTC: CSBR) ("Champions" or "the Company") announced today that it has exercised an option to license Irinophore C™, a liposomal formulation of Irinotecan, from the BC Cancer Agency ("BCCA") in British Columbia, Canada. This action was the result of the positive results obtained from a Tumorgraft™ study done on Irinophore C™ utilizing Champions' proprietary technology platform.

Irinophore C™ is a lipid-based nanoparticle made by efficiently loading the irinotecan payload into its interior core using a novel and proprietary method. The compound is currently completing preclinical development and is due to enter phase I clinical study as a single agent in patients having advanced solid tumors in Q4 2011.  Champions tested the activity of Irinophore C™ using its Tumorgraft™ translational technology platform.  The results demonstrated significant efficacy and safety advantages in Irinophore C™ as compared to the approved drug Irinotecan (Camptosar) on various tumor types.

In February 2010, Champions entered into an exclusive option agreement with BCCA for the exclusive right to review Irinophore C™ for the treatment of various forms of solid tumor cancer. The exercise of the option will result in immediate costs to the Company of approximately $85,000 comprised of the option exercise price and reimbursement to BCCA for past patent costs. Champions is currently exploring strategic options for financing the clinical development costs of Irinophore C™.

The Company also announced that it will not pursue further any of the three compounds for which it signed licensing agreements. The Company's scientific advisory committee has reviewed the results of the Tumorgraft™ studies performed on each of these compounds and recommended that the Company stop investing resources in the development of these compoun
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Champions CFO Resigns
2. Champions Biotechnology Awarded $1.46 million in Grants
3. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
4. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
5. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
6. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
7. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
8. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
11. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer will lead the call. ... Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, ...
(Date:7/27/2015)... 2015  Linear accelerators used to treat patients ... only adequate space for the equipment itself, but ... to the size and complexity of the technology, ... addition of a new vault constitutes a formidable ... of patient treatment: with potential negative long-term effects ...
(Date:7/27/2015)... , July 27, 2015 Dynatronics Corporation (NASDAQ: ... its Solaris therapeutic modality products. This approval allows the company to ... other countries around the world. "Receiving the CE Mark ... efforts," stated Kelvyn H. Cullimore Jr. , president and CEO ... distribution network into China , Japan ...
Breaking Medicine Technology:Accelerating the Design Process for Cancer Treatment Centers 2Accelerating the Design Process for Cancer Treatment Centers 3Dynatronics Awarded CE Mark Approval for Its Solaris Products 2
... March 22, 2011 Instrumentation Laboratory (IL) today announced ... ($644.9 million US). This represents 11.5% growth v. previous ... the Company,s two major business segments, Critical Care and ... (11.9% in local currencies) and 9.7% (8.9% in local ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... currently Valeant,s Chief Executive Officer (CEO), as Chairman of the ... the Valeant Board as an independent Board Director and Lead ... and has agreed to extend his contract through to February ...
Cached Medicine Technology:Instrumentation Laboratory Achieves Record Sales in 2010 2Instrumentation Laboratory Achieves Record Sales in 2010 3
(Date:7/27/2015)... ... July 27, 2015 , ... ... a professional and in-depth research report. The report provides basic information such ... analysis etc. This report covers the global (US, Europe, Japan etc) industry ...
(Date:7/27/2015)... ... ... Gary D. Breslow, MD, FACS, is a highly regarded board certified plastic ... Breslow Center in Paramus, NJ, which offers the most complete range of state-of-the-art plastic ... Breslow Center also hosts a world-class medical spa which offers cutting edge non-invasive laser ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a creative effort to ... restore a healthy lifestyle, The Ranch at Dove Tree in Lubbock has shared a ... easily through the steps of recovery. Both the nationally recognized collegiate program and traditional ...
(Date:7/27/2015)... ... 2015 , ... Sher Fertility Institute, a national network of fertility ... physician to their clinical team in Las Vegas. , Dr. Mark Severino ... successful Reproductive Endocrinology teams in the region. , Combined Drs. Sher and Severino have ...
(Date:7/27/2015)... ... July 27, 2015 , ... Standifer Insurance Group, a ... drive that will support Camp Conquest, a specialized camp for young people who have ... Conquest offers a five day and four night curriculum designed to give burn survivors ...
Breaking Medicine News(10 mins):Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3Health News:NJ Top Doc, Dr. Gary Breslow, has launched Zwivel; a New Online Cosmetic Consultation Service for Doctors and Patients 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 2Health News:Standifer Insurance Group and Camp Conquest Plan Joint Charity Initiative to Assist Hospitalized Children Suffering from Burn Injuries 3
... this year's Ellis Island Medal of Honor, established by the ... ,Jacob Eapen, who will receive the award May ... to be a boost for all my future endeavours," Eapen ... Island Medals of Honor are presented annually to US citizens ...
... team of researchers has confirmed that the malfunction of ... a study published Thursday's issue of the journal Neuron. ... a possible animal model for developing treatments for schizophrenia ... genetic mechanisms by the researchers. ,In their ...
... Resource Development in collaboration with National AIDS Control Organisation ... Adolescence Education Programme (AEP) which is being implemented by ... ,The Programme is aimed at the ... of the major concerns, i.e. process of growing up ...
... people know about the dangers of global warming, but only ... Andreas Ernst of the University of Kassel, has two parts. ... the other, the human species is biologically programmed to act ... very different from common rats on that point. ...
... and state representatives from 105 countries met Friday to formally ... worse impacts of global warming after five days of heated ... ,"The discussions ended at 3:30 a.m. Friday," said Carloa Traverso ... Change (IPCC). ,Once the IPCC report is formally ...
... proudly announces the launch of the General Practice Student ... Registrars Association (GPRA). ,The GPSN will ... the specialty of General Practice, and those keen to ... ,AMSA National President Mr. Rob Mitchell said, ...
Cached Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Why Humans Fail to Act on Climate Change 2Health News:Why Humans Fail to Act on Climate Change 3Health News:Climate Talks Reach Consensus in Bangkok 2
... The SYNCHRON CX5-S workstation ... electrolyte testing, targeted to the ... than 200 samples per day. ... the CX5-S is easy to ...
... the high-volume lab, the SYNCHRON LX4201 simplifies ... up to 2,880 tests per hour. By ... SYNCHRON LX4201 with broad menu, speed and ... come to expect from Beckman Coulter-innovative, reliable ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... the power of the LX2000 Series ... resources without compromising testing quality.Plus, when ... LX20 PRO, you get advanced features ... other chemistry analyzer, including closed tube ...
Medicine Products: